ZYDELIG is a prescription medicine used to treat adults with Chronic Lymphocytic Leukemia (CLL) in combination with Rituxan® (rituximab) when the disease comes back after prior cancer treatment. It is used in patients who may otherwise be treated with Rituxan alone due to other health concerns.
ZYDELIG should not be used as the first medicine to treat people who have been diagnosed with CLL.
Living with recurrent or relapsed Chronic Lymphocytic Leukemia (CLL) can be challenging. You've already been through at least one treatment regimen, only to have your cancer return. This time around, your doctor has prescribed an alternative treatment approach for your relapsed CLL. ZYDELIG is the first of a new class of drug used in combination with Rituxan® (rituximab) when CLL comes back after prior cancer treatment.
A guide to how ZYDELIG works, talking to your doctor as well as taking and storing it.Learn More›
Information about managing certain side effects associated with ZYDELIG.Learn About Possible Side Effects›